Probabilities
|
PTNS ⩾50% improvement |
0.6200 |
0.0300 |
beta |
161.6822 |
99.0956 |
Proceeding to permanent SNS |
0.7350 |
0.1500 |
beta |
5.6277 |
2.0290 |
SNS_⩾50% improvement |
0.7750 |
0.0350 |
beta |
109.5439 |
31.8031 |
Adverse events for temporary SNS |
0.2039 |
0.0828 |
beta |
4.6281 |
18.0740 |
Adverse events for permanent SNS |
0.2487 |
0.0625 |
beta |
11.6484 |
35.1864 |
QALY
|
PTNS ⩾50% improvement |
3.3743 |
0.5087 |
normal |
44.0037 |
13.0407 |
PTNS discontinued |
2.8793 |
0.3233 |
normal |
79.3048 |
27.5434 |
Temporary SNS_adverse_no_implant |
2.8710 |
0.3191 |
normal |
80.9752 |
28.2043 |
QALY_TempSNS_no_adverse_no_implant |
2.8793 |
0.3233 |
normal |
79.3048 |
27.5434 |
QALY_PermSNS_adverse2_improved |
3.3579 |
0.4989 |
normal |
45.3080 |
13.4931 |
QALY_PermSNS_adverse2_not_improved |
2.8628 |
0.3148 |
normal |
82.6991 |
28.8878 |
QALY_PermSNS_adverse1_improved |
3.3743 |
0.5087 |
normal |
44.0037 |
13.0407 |
QALY_PermSNS_adverse1_not_improved |
2.8710 |
0.3191 |
normal |
80.9752 |
28.2043 |
QALY_PermSNS_no_adverse_not_improved |
2.8793 |
0.3233 |
normal |
79.3048 |
27.5434 |
QALY_PermSNS_no_adverse_improved |
3.3743 |
0.5087 |
normal |
44.0037 |
13.0407 |
Costs PTNS
|
⩾50% improvement |
4,040.61 |
715.54 |
gamma |
31.8881 |
0.0079 |
No improvement |
2,364.21 |
422.01 |
gamma |
31.3860 |
0.0133 |
Discontinued |
607.49 |
30.62 |
gamma |
393.7170 |
0.6481 |
Costs SNS
|
Temporary SNS, no adverse events |
1,562.94 |
190.97 |
gamma |
66.9787 |
0.0429 |
Temporary SNS, adverse events |
2,229.23 |
358.08 |
gamma |
38.7578 |
0.0174 |
Permanent SNS, no adverse events, ⩾50% improvement |
14,103.89 |
2,525.38 |
gamma |
31.1906 |
0.0022 |
Permanent SNS, no adverse events, no improvement |
13,267.37 |
2,363.65 |
gamma |
31.5067 |
0.0024 |
Temporary SNS with adverse events + permanent SNS with adverse
events, ⩾50% improvement |
18,150.79 |
3,898.14 |
gamma |
21.6808 |
0.0012 |
Temporary SNS with adverse events + permanent SNS with adverse
events, no improvement |
17,314.27 |
3,736.41 |
gamma |
21.4733 |
0.0012 |
Temporary SNS with adverse events + permanent SNS no adverse
events, ⩾50% improvement |
14,770.18 |
2,692.45 |
gamma |
30.0937 |
0.0020 |
Temporary SNS with adverse events + permanent SNS no adverse
events, no improvement |
13,933.66 |
2,530.72 |
gamma |
30.3140 |
0.0022 |
Temporary SNS no adverse events + permanent SNS with adverse
events, ⩾50% improvement |
17,484.51 |
3,731.08 |
gamma |
21.9603 |
0.0013 |
Temporary SNS no adverse events + permanent SNS with adverse
events, no improvement |
16,647.98 |
3,569.34 |
gamma |
21.7544 |
0.0013 |
Costs PTNS+SNS
|
PTNS + temporary SNS, no adverse events |
3,927.15 |
521.86 |
gamma |
56.6305 |
0.0144 |
PTNS + temporary SNS, adverse events |
4,593.44 |
643.92 |
gamma |
50.8871 |
0.0111 |
PTNS + permanent SNS, no adverse events, ⩾50% improvement |
16,468.11 |
2,697.60 |
gamma |
37.2677 |
0.0023 |
PTNS + permanent SNS, no adverse events, no improvement |
15,631.58 |
2,537.74 |
gamma |
37.9412 |
0.0024 |
PTNS + temporary SNS with adverse events + permanent SNS with
adverse events, ⩾50% improvement |
20,515.01 |
4,060.83 |
gamma |
25.5219 |
0.0012 |
PTNS + temporary SNS with adverse events + permanent SNS with
adverse events, no improvement |
19,678.49 |
3,899.93 |
gamma |
25.4607 |
0.0013 |
PTNS + temporary SNS with adverse events + permanent SNS no
adverse events, ⩾50% improvement |
17,134.39 |
2,863.45 |
gamma |
35.8063 |
0.0021 |
PTNS + temporary SNS with adverse events + permanent SNS no
adverse events, no improvement |
16,297.87 |
2,703.40 |
gamma |
36.3447 |
0.0022 |
PTNS + temporary SNS no adverse events + permanent SNS with
adverse events, ⩾50% improvement |
19,848.72 |
3,894.26 |
gamma |
25.9786 |
0.0013 |
PTNS + temporary SNS no adverse events + permanent SNS with
adverse events, no improvement |
19,012.20 |
3,733.41 |
gamma |
25.9331 |
0.0014 |